Kepler Neutron Deal Adds Launch Backlog But Valuation Stretch Persists

What happened

Rocket Lab has sold a dedicated Neutron flight to Kepler, marking another commercial commitment as the company approaches its first medium-lift launch. However, the article underscores that the bulk of Neutron's value lies not in launch fees but in unlocking new revenue opportunities, consistent with Rocket Lab's pivot toward integrated space systems. The master report notes that while space systems revenue surged 63% year-over-year and backlog reached $2.36 billion, launch services remained a smaller segment at $108 million in the first half of 2026. With the stock trading near $74, the market already appears to discount successful Neutron milestones and margin improvement, leaving minimal room for execution missteps. Given the WAIT rating and implied base value of $76, the Kepler deal is incremental but does not resolve the key risks of Neutron timing and ongoing EBITDA losses.

Implication

While the commercial interest in Neutron is encouraging, Rocket Lab's valuation already discounts successful execution; the stock remains unattractive until Neutron reaches pad delivery and static fire, and EBITDA losses narrow significantly. The WAIT rating stands, with a more attractive entry near $60.

Thesis delta

The sale of a dedicated Neutron flight to Kepler is a positive commercial signal but does not alter the core valuation concern. The thesis remains unchanged: Rocket Lab's diversified space systems business is growing, but the stock price already prices in successful Neutron debut and margin improvement. The WAIT rating and waiting for a lower entry or clearer milestones is unchanged.